APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 75 filers reported holding APTINYX INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $46,000 | -47.7% | 124,041 | -21.3% | 0.00% | -50.0% |
| Q2 2022 | $88,000 | -81.3% | 157,641 | -24.0% | 0.00% | -77.8% |
| Q1 2022 | $471,000 | -31.4% | 207,300 | -19.4% | 0.01% | -30.8% |
| Q4 2021 | $687,000 | -31.5% | 257,300 | -40.0% | 0.01% | -31.6% |
| Q3 2021 | $1,003,000 | +33.6% | 428,700 | +61.6% | 0.02% | +46.2% |
| Q2 2021 | $751,000 | -5.7% | 265,300 | 0.0% | 0.01% | -13.3% |
| Q1 2021 | $796,000 | +58.3% | 265,300 | +82.6% | 0.02% | +36.4% |
| Q4 2020 | $503,000 | +64.9% | 145,300 | +60.9% | 0.01% | +57.1% |
| Q3 2020 | $305,000 | -50.0% | 90,300 | -38.3% | 0.01% | -41.7% |
| Q2 2020 | $610,000 | +93.0% | 146,300 | 0.0% | 0.01% | +71.4% |
| Q1 2020 | $316,000 | -36.8% | 146,300 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $500,000 | +64.5% | 146,300 | +68.2% | 0.01% | +75.0% |
| Q3 2019 | $304,000 | – | 87,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
| ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
| Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
| Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
| Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
| NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
| DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
| Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
| Orbimed Advisors | 538,500 | $300,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |